Study S000941

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/Obesity (OOB)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07292519
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: DOUBLE
Status: NOT_YET_RECRUITING
Enrollment: 46
Start: 2026-01-15
Primary completion: 2027-05-15
Lead sponsor: South West Sydney Local Health District
Conditions: Alcohol Use Disorder (AUD); Overweight or Obese; Comorbidities and Coexisting Conditions
Interventions: DRUG:Tirzepatide; BEHAVIORAL:Take Control CBT Module; OTHER:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Heavy Drinking Days [12 weeks (measured at baseline, during the final 4 weeks of treatment [weeks 5 - 8], end of treatment [week 9], and follow-up [week 12]).]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.